Friday's sharp decline for stocks, spurred by concerns over a new Covid-19 variant, is not a buying opportunity, according to CNBC's Jim Cramer."We're going...
Check out the companies making headlines in midday trading.Merck — Shares surged 8.4% after it announced its new antiviral pill cut the risk of death...
A pharmacist displays a box of tocilizumab, which is used in the treatment of rheumatoid arthritis, at the pharmacy of Cambrai hospital, France, April...
View of Corporate and Research and Development Headquarters of Regeneron Pharmaceuticals on Old Saw Mill River Road in Tarrytown, New York.Lev Radin | LightRocket...
Eli Lilly Chairman and CEO Dave Ricks told CNBC on Tuesday that he believes the company's coronavirus antibody treatment will still be beneficial to Covid-19...
In this May 2020 photo provided by Eli Lilly, researchers prepare mammalian cells to produce possible COVID-19 antibodies for testing in a laboratory in...
Gilead Sciences will have sufficient global supply of its coronavirus treatment remdesivir by the end of October, CEO Daniel O'Day told CNBC on Friday. The comments come...
President Donald Trump releases another video on Twitter on Oct. 8th, 2020.The White HousePresident Donald Trump said Thursday that he's not contagious "at all"...